Four things to know:
1. Alexa Boer Kimball, MD, is one of the candidates. She serves as a dermatology professor at Cambridge, Mass.-based Harvard University and CEO of Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center in Boston.
2. The other candidate is a physician at the MD Anderson Cancer Center in Houston, according to people familiar with the discussions who declined to identify the person.
3. Dr. Sharpless, a favorite to secure the post, became acting FDA commissioner in April, when Scott Gottlieb resigned. Before taking on his role at the FDA, Dr. Sharpless was director of the National Cancer Institute.
4. A White House official told the Journal that other candidates are in the running.
Read the full report here.
More articles on pharmacy:
Lupin recalls 18,408 bottles of antibiotic in US
Bluebird Bio prices gene therapy at $1.8M
10 hospitals seeking pharmacy leaders
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.